CYCCP - Cyclacel Pharmaceuticals' (CYCC) CEO Spiro Rombotis on Q3 2020 Results - Earnings Call Transcript
Cyclacel Pharmaceuticals, Inc. (CYCC) Q3 2020 Earnings Conference Call November 11, 2020 4:30 PM ET Company Participants Eric Ando – Investor Relations Spiro Rombotis – President and Chief Executive Officer Paul McBarron – Executive Vice President, Finance and Chief Operating Officer Mark Kirschbaum – Senior Vice President and Chief Medical Officer Conference Call Participants Jonathan Aschoff – Roth Capital Partners Kumar Raja – Brookline Capital Wangzhi Li – Ladenburg Presentation Operator Good afternoon, and welcome to the Cyclacel Pharmaceuticals’ Third Quarter 2020 Results Conference Call and Webcast. [Operator Instructions] The company will also be accepting a limited number of questions submitted via e-mail to the address ir@cyclacel.com. [Operator Instructions] Please note that today's call is being recorded. I would now like to turn the conference over to the company. Eric Ando Thank you, Erica. Good afternoon everyone. And thank you for joining today's conference call to discuss Cyclacel's financial results
For further details see:
Cyclacel Pharmaceuticals' (CYCC) CEO Spiro Rombotis on Q3 2020 Results - Earnings Call Transcript